10 principais biotechtv.com concorrentes

instilbio.com

Send us a message.

longwoodfund.com

John McCabe is Portfolio Company Chief Financial and Chief Operating Officer at Longwood Fund and the COO/CFO of Longwood-founded companies Solu Therapeutics, Weaver, and DEM Bio.

keloniatx.com

Kelonia’s lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for relapsed/refractory multiple myeloma with clinical data recently highlighted in the 2025 ASH Annual Meeting plenary session Acquisition expands Lilly’s genetic medicine capabilities with a novel in vivo gene delivery and integration technology that has potential for broad […]

neurvati.com

At Neurvati, we’re taking a different approach to advancing neuroscience product development with the goal of accelerating treatment options and access for patients in need, globally.

dewpointx.com

Poster presented at the 2024 International Rett Syndrome Foundation Scientific Meeting > Download the PDF file

tennr.com

Explore Tennr's content library, featuring videos, customer and expert interviews, whitepapers, webinars, and more.

hatterasvp.com

CAMBRIDGE, Mass., March 12, 2020 /PRNewswire/ — Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough protein degrader medicines for patients, today announced the closing of a $102 million Series C financing. The round was led by Biotechnology Value Fund (BVF) and Redmile Group with participation from Wellington Management Company, Bain Capital Life Sciences, funds managed […]

averincapital.com

The past month has made one thing clear: healthcare’s AI future is no longer hypothetical. Epic unveiled Emmie, Art, and CoMET, OpenAI staffed up with…

rayzebio.com

Purposefully designing the discovery and development of innovative radiopharmaceuticals for solid tumors.

moonlaketx.com

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company that provides next-level therapies to elevate care.